Deepvoxel

22 Talisman, Irvine, CA 92620, USA All United States companies →

Imaging AI Specialist Specialty-Focused AI

Oncology Radiology

Oncology AI Radiology & Imaging AI

Claim this company

Products

DV. Target

Deepvoxel Inc.

Oncology AI

Deepvoxel DV. Target is an FDA-cleared AI software that automatically delineates organs-at-risk (OARs) on CT images for radiation therapy planning, enhancing accuracy and efficiency.

See all 1 product →

About Deepvoxel

DeepVoxel Analytics is a company specializing in pattern recognition, data-mining, and signal processing technologies with significant applications in medical imaging and diagnostics. The company develops sophisticated software platforms designed for high-dimensional feature analysis and various image processing functions. A notable application includes the automated quantification of atherosclerotic plaque from magnetic resonance images, a process evaluated by the Vascular Imaging Laboratory at the Mount Sinai School of Medicine, which found its performance to closely match that of human experts.

Beyond medical diagnostics, DeepVoxel Analytics has a proven track record of delivering analytical solutions in engineering and hard sciences, with case studies involving the U.S. Department of Defense and the National Institutes of Health. These projects include areas such as multi-sensor fusion for precision measurement systems. The company’s expertise also extends to interactive software for time-series and event-based data, aiding analysts in gaining deeper insights from complex data streams.

Focus Areas

Medical imaging image analytics pattern recognition automated lesion quantification atherosclerotic plaque identification radiation therapy planning auto-contouring of organs-at-risk (OARs)

Business Intelligence

Partnerships	Vascular Imaging Laboratory at the Mount Sinai School of Medicine (for system evaluation)
Technology	Software platform supporting high-dimensional feature analysis and image processing functions; utilizes machine learning-based algorithms for auto-contouring; DV.Target is a standalone software installed on a specialized server supporting deep learning processing.
FDA Clearances	1 cleared products (estimated)

What Physicians Need to Know

Medical Imaging & Image Analytics

Deepvoxel specializes in advanced image analytics and pattern recognition within medical diagnostics, developing software and algorithms to solve complex problems.

Automated Lesion Quantification

The company provides innovative algorithms and a software suite for automated lesion quantification, with a system evaluated by the Vascular Imaging Laboratory at Mount Sinai School of Medicine, demonstrating performance comparable to human experts.

Atherosclerotic Plaque Identification

Deepvoxel offers an image processing platform capable of predictive classification of magnetic resonance images to identify atherosclerotic plaque, supporting 3D multiple-contrast image data.

Key Differentiators

Deepvoxel stands out due to its innovative algorithms, a proven track record of analytics successes with institutions like the National Institutes of Health, and the ability of its systems to closely match human expert performance in complex tasks like lesion quantification.

Technology Stack

Their DeepVoxel EventAnalytics software is developed in Matlab and integrates with other statistical software like R via standard formats such as CSV, with options for custom connections. It supports high-dimensional feature analysis.

Physician Tip

For physicians, Deepvoxel's solutions offer significant advantages in automating laborious image analysis tasks, such as atherosclerotic plaque evaluation and lesion quantification, potentially saving considerable time and reducing inter-observer variability. The validated accuracy, which closely matches human expert performance, provides a reliable tool for diagnostic support. Consider how their analytics suite can integrate with your existing statistical software (Matlab, R) and inquire about custom connections to streamline your workflow. While the provided information highlights their expertise in lesion and plaque analysis, direct details on radiation therapy planning and auto-contouring of organs-at-risk were not explicitly found in the available snippets for 'Deepvoxel Analytics'.

Deepvoxel's DeepVoxel EventAnalytics software is designed for integration with existing statistical software environments such as Matlab and R, utilizing standard data formats like CSV. Custom data connections can be developed upon request, allowing for flexible integration into diverse clinical and research workflows. The software can also function as a presentation layer with existing R or Matlab applications.

Products by Deepvoxel

1 product in the directory

DV. Target

Deepvoxel Inc.

Oncology AI

Deepvoxel DV. Target is an FDA-cleared AI software that automatically delineates organs-at-risk (OARs) on CT images for radiation therapy planning, enhancing accuracy and efficiency.

What the Web Says

Deepvoxel appears to be a company with limited public review presence across major platforms like G2, Glassdoor, and Capterra. Information regarding product reviews and employer experiences is scarce, making it difficult to form a comprehensive opinion. The available mentions are very limited and do not provide substantial insights into their offerings or work environment.

Overall: Mixed

Strengths

Information not available due to limited reviews.
Unknown
Unknown
Unknown
Unknown
Unknown

Limitations

Lack of public reviews on major platforms (G2, Glassdoor, Capterra).
Limited information available about products or services.
Scarcity of employer reviews or insights into company culture.
Difficulty in assessing product quality or customer satisfaction.
Unknown
Unknown

Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT Reviewers (no specific reviews found), Reddit (no specific reviews found)

Last updated: 2026-07-18

Videos

News, demos, and interviews about Deepvoxel.

Loading videos...

Videos load interactively. If none appear, search YouTube for Deepvoxel →

View all on YouTube

Press & Coverage

PR Newswire

Voxel Raises $44M in Series B Funding to Transform Workplace Safety with its AI-Powered Platform

Voxel, an AI company focused on workplace safety, announced a $44 million Series B funding round, bringing its total funding to $61 million. The company plans to use the funds to accelerate R&D and expand its AI capabilities to prevent accidents in industrial environments.

2025-06

PR Newswire

Voxel Expands Global Reach and Leadership Bench to Power the Next Era of AI Safety

Voxel, a computer vision AI company, has expanded its global operations to seven new countries and made strategic C-suite hires, following a $44 million Series B funding round. The company is experiencing significant momentum in enterprise workplace safety.

2025-08

DC Velocity

Voxel raises $44 million for visual AI that prevents accidents

California-based startup Voxel secured $44 million in Series B funding for its AI technology that analyzes security camera video feeds in real-time to identify potential hazards and unsafe behaviors in industrial settings.

2025-06

Journal for Immunotherapy of Cancer (PMC - NIH)

Voxel-level radiomics and deep learning for predicting pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant immunotherapy and chemotherapy

This study introduces a novel deep learning model, Vision-Mamba, which integrates voxel-level radiomics and CT images to predict pathologic complete response in patients with esophageal squamous cell carcinoma after neoadjuvant immunotherapy and chemotherapy.

2025-03

Cell Reports Medicine (PMC - NIH)

An accessible deep learning tool for voxel-wise classification of brain malignancies from perfusion MRI

Researchers developed a deep learning-based tool that utilizes the full spatial and temporal information of perfusion MRI for voxel-wise classification of brain malignancies, outperforming conventional methods.

2024-03

TechNews180

AI-Powered Voxel Secures $30M to Shield Industrial Workers

Voxel, an AI startup, secured a $12 million strategic funding round, led by Rite-Hite, bringing its total funding to $30 million. The company uses computer vision to enhance workplace safety and operations in industrial domains.

2023-09

Nasdaq

AI for good: Voxel AI tech is saving industrial workers' lives as it increases funding to $30m with strategic funding round

Voxel, an AI startup using computer vision to transform workplace safety, announced a $12 million strategic funding round, increasing its total funds raised to $30 million since 2020. The investment aims to expand operations and improve workplace safety.

2023-08

ResearchGate

DeepVoxels: Learning Persistent 3D Feature Embeddings

This research paper introduces DeepVoxels, a learned representation that encodes the view-dependent appearance of a 3D scene without explicitly modeling its geometry, using a Cartesian 3D grid of persistent embedded features.

2019-06

Frequently Asked Questions

What specific medical imaging products does Deepvoxel offer for clinical use?

Deepvoxel, Inc. offers DV.Target, an FDA 510(k) cleared software application designed for the automatic delineation of organs-at-risk (OARs) on CT images to facilitate radiation therapy planning workflows. Additionally, Deepvoxel has developed a software platform for predictive classification of magnetic resonance images to identify atherosclerotic plaque and a suite for automated lesion quantification.

How does Deepvoxel ensure compliance with medical regulations and data privacy standards like HIPAA and DICOM?

Deepvoxel's DV.Target device is FDA 510(k) cleared and requires DICOM 3.0 compliance for image data processing. While specific HIPAA compliance details for Deepvoxel were not found, any medical AI solution handling Protected Health Information (PHI) must adhere to HIPAA regulations, which typically involves robust technical safeguards, data de-identification, and secure infrastructure.

Can Deepvoxel's image analytics solutions integrate with our existing PACS or radiation therapy planning systems?

Deepvoxel's DV.Target is designed to process DICOM image data, indicating compatibility with standard medical imaging formats. The deployment environment for DV.Target is recommended to be a local network with an existing hospital-grade IT system, suggesting integration capabilities with current hospital infrastructure.

What is Deepvoxel's pricing model for its medical imaging and analytics software?

Specific pricing details for Deepvoxel's medical imaging and analytics software are not publicly available. Pricing for such specialized healthcare AI solutions is typically customized based on the institution's size, specific product modules required, and deployment model. Interested parties would likely need to request a direct quotation.

What kind of customer support and training does Deepvoxel provide for its products?

While explicit details on Deepvoxel's customer support and training programs were not found, medical device companies typically offer comprehensive support, including installation assistance, technical troubleshooting, and training for medical professionals to ensure proper and effective use of their specialized software. Users are expected to be trained medical professionals.

What is the company's background and stability, and are there any notable partnerships?

Deepvoxel Analytics' founders and advisors have a strong background in medical imaging, financial services, engineering, and marketing, with a track record of analytics successes for organizations like the DoD and NIH. While specific current partnerships for their medical products were not detailed, an advisor has a history of creating significant alliances with major tech companies.

Related Companies

Suggest an Edit →